Intuitive Surgical

{NAS.ISRG} is a dominant leader in the robotic-assisted surgery market, known for its da Vinci surgical systems.

Earnings Alert: Q1 2026

You’re not a member!  Trial today

  • Release Date: Tomorrow, April 21, 2026, after market close.
  • Estimates: Analysts expect EPS of approximately $2.08 – $2.16 on revenue of $2.61 – $2.67 billion.

Key Focus: Investors will be watching for updates on the rollout of the da Vinci 5* and commentary on 2026 procedure growth guidance (currently 13–15%).

Fundamental Metrics

  • Market Cap: ~$166.65 Billion.
  • Valuation:

* Forward P/E: 41.06x
* Trailing P/E: 59.54x
* Price-to-Book: 9.35x

  • Analyst Sentiment: Rated as a Buy (Average Rating: 1.9) with a median price target generally cited near $600, implying significant potential upside from current levels.

Recent Developments & Catalysts
FDA Expansions: In early 2026, the company received FDA clearance for the da Vinci 5for select cardiac procedures and recently expanded da Vinci SP* indications to include inguinal hernia and appendectomy.

  • Operational Milestone: The company reached a milestone of 20 million procedures performed globally in January 2026, reinforcing its massive “razor-and-blade” recurring revenue model (instruments and accessories).
  • Guidance Caution: The stock has seen some pressure in early 2026 due to conservative procedure growth guidance (13-15% vs. 18% in 2025), as the company laps tough year-over-year comparisons.

Performance Context

  • 52-Week Range: $427.84 – $603.88.
  • Technical Trend: The stock is currently trading below its 200-day moving average ($503.09), suggesting it is in a period of consolidation or correction ahead of its earnings results. It has underperformed the broader S&P 500 YTD by approximately 18%.

Actionable Insight: ISRG remains a high-quality growth play, but current valuation multiples reflect high expectations. Tomorrow’s earnings call will be critical to determine if the 2026 growth deceleration is fully priced in.

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.